Method of assessing diabetic nephropathy using CD5 antigen-like
US9146243B2 · kind B2 · utility
2Cited by
0References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 14, 2014 |
| Grant date | Sep 29, 2015 |
| Priority date | — |
| Expiry date | May 14, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/50
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.